Zusammenhänge zwischen metabolischem Syndrom, Depression, Stress und körperlicher Aktivität

Zusammenfassung

Anliegen Untersuchung der Zusammenhänge zwischen metabolischem Syndrom (MTS) und Depression. Methode Medline-Literaturrecherche. Ergebnisse Das MTS begünstigt die Entwicklung depressiver Störungen und umgekehrt. Beide Erkrankungen sind mit Insulinresistenz, Diabetes mellitus Typ 2, Adipositas und erhöhtem Herzinfarktrisiko assoziiert. Bewegungsmangel, Überernährung, Adipositas und Stress spielen für die Genese des MTS und möglicherweise auch für die der Depression eine Rolle. Schlussfolgerungen Körperliche Aktivität wirkt sich positiv auf alle Einzelfaktoren des MTS, besonders auf die Insulinresistenz, aus. Körperliche Aktivität hat aber auch antidepressive Effekte. Tierexperimentelle Studien zeigen, dass körperliche Aktivität grundsätzlich von großer Bedeutung für die Gehirngesundheit sein könnte, wobei besonders auf die hippokampale Neuroplastizität hinzuweisen ist.

Abstract

Objective Analysis of coherences between metabolic syndrome (MTS) and depression. Methods Literature research in Medline. Results The metabolic syndrome (MTS) is characterized by the coexistence of (abdominal) obesity, type 2 diabetes, hypertension and dyslipidaemia while insulin resistance is one pathophysiological key factor. MTS is a risk factor for the development of depressive disorders and vice versa. MTS (usually) and depression (quite often) are associated with insulin resistance, type 2 diabetes, obesity and increased risk of myocardial infarction. Environmental factors like lack of physical exercise, malnutrition and stress may play an important role in the genesis of both disorders. Conclusions On the one hand, physical activity has positive effects on all elements of MTS, especially insulin resistance, on the other hand, mild antidepressant effects of physical activity have been demonstrated. The results of animal experiments refer to the essential relevance of physical activity concerning „brain health”, specifically with respect to hippocampal neuroplasticity.

metabolisches Syndrom - Depression - körperliche Aktivität - Stress

metabolic syndrome - depression - physical activity - stress

Literatur

• 1 Ayuso-Mateos J L, Vasques-Barquero D, Dowrick V. et al . Depressive disorders in Europe: prevalence figures from the ODIN study.  Br J Psychiatry. 2001;  173 308-316
• 2 Engum A, Mykletun A, Midthejell K. et al . Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes.  Diab Care. 2005;  28 1904-1909
• 3 Ford E S, Wayne H G, Mokdad A H. Increasing prevalence of the metabolic syndrome among US adults.  Diab Care. 2004;  27 2444-2449
• 4 Fried L P, Kronmal R A, Newman A B. et al . Risk factors for 5-year mortality in older adults: the cardiovascular health study.  JAMA. 1998;  279 585-592
• 5 Haslam D W, James W P. Obesity.  Lancet. 2005;  366 1197-1209
• 6 Hanefeld M, Leonhardt W. Das metabolische Syndrom.  Dtsch Gesundheitswesen. 1981;  36 545-551
• 7 Reaven G M. Banting Lecture 1988. Role of insulin resistance in human disease.  Diabetes. 1988;  37 1595-607
• 8 Everson-Rose S A, Meyer P M, Poell L H. et al . Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife.  Diab Care. 2004;  27 2856-2862
• 9 Isomaa B, Lahti K, Almengren P. et al . Cardiovascular morbidity and mortality associated with the metabolic syndrome.  Diab Care. 2001;  24 683-689
• 10 Heiskanen T H, Niskanen L K, Hintikka J J. et al . Metabolic syndrome and depression: a cross-sectional analysis.  J Clin Psychiatry. 2006;  67 1422-1427
• 11 Kahl K G. The metabolic syndrome and mental illness: relevance, risk factors and practical consequences.  MMW Fortschr Med. 2005;  147 32-36
• 12 Tuomilehto J, Lindström J, Eriksson J G. et al . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.  N Engl J Med. 2001;  244 1343-1350
• 13 Gans R O. The metabolic syndrome, depression and cardiovascular disease: interrelated conditions that share pathophysiologic mechanism.  Med Clin North Am. 2006;  90 573-591
• 14 Anisman H, Merali Z. Cytokines, stress, and depressive illness.  Brain Behav Immun. 2002;  16 513-524
• 15 Ford E S, Li C. Physical activity or fitness and the metabolic syndrome.  Expert Rev Cardiovasc Ther. 2006;  4 897-915
• 16 Weber-Hamann B, Hentschel F, Kniest A. et al . Hypercortisolemic depression is associated with increased intra-abdominal fat.  Psychosom Med. 2002;  64 274-277
• 17 Bruce E C, Musselman D L. Depression, alternations in platelet function, and ischemic heart disease.  Psychosom Med. 2005;  67, Suppl. 1 34-36
• 18 Carney R M, Freedland K E, Veith R C. Depression the autonomic nervous system, and coronary heart disease.  Psychosom Med. 2005;  67, Suppl. 1 29-33
• 19 Rugulies R. Depression as a predictor for coronary heart disease. A review and metaanalysis.  Am J Prev Med. 2002;  23 51-61
• 20 Ramasubbu R. Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases.  Med Hypotheses. 2002;  59 537-551
• 21 Timonen M, Laakso M, Jokelainen J. et al . Insulin resistance and depression: cross sectional study.  BMJ. 2005;  330 17-18
• 22 Wirth A. Adipositas und Metabolisches Syndrom.  Cardiovasc. 2003;  3 22-30
• 23 Spieker L E, Hurlimann D, Ruschitzka F. et al . Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors.  Circulation. 2002;  105 2817-2820
• 24 Sapolsky R M. Why stress is bad for your brain.  Science. 1996;  273 749-750
• 25 Sapolsky R M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.  Arch Gen Psychiatry. 2000;  57 925-935
• 26 Tsatsoulis A, Fountoulakis S. The protective role of exercise on stress system dysregulation and comorbidities.  Ann NY Acad Sci. 2006;  1083 196-213
• 27 Fuchs E, Czeh B, Kole M HP. et al . Alterations of neuroplasticity in depression: the hippocampus and beyond.  Eur Neuropsychopharmacol. 2004;  14, Suppl. 5 481-490
• 28 Henn F A, Vollmayr B. Neurogenesis and depression: etiology or epiphenomenon?.  Biol Psychiatry. 2004;  56 146-150
• 29 Malberg J E. Implications of adult hippocampal neurogenesis in antidepressant action.  J Psychiatry Neurosci. 2004;  29 196-205
• 30 McEwen B S. Stress and hippocampal plasticity.  Annu Rev Neurosci. 1999;  22 105-122
• 31 Akil H, Haskett R F, Young E A. et al . Multiple HPA profiles in endogenous depression: effect of age and sex on cortisole and beta-endorpin.  Biol Psychiatry. 1993;  33 73-85
• 32 Ströhle A. Die Neuroendokrinologie von Stress und die Pathophysiologie und Therapie von Depression und Angst.  Nervenarzt. 2003;  74 279-292
• 33 Cotman C W, Berchtold N C. Exercise: A behavioral intervention to enhance brain health and plasticity.  Trends Neurosci. 2002;  25 295-301
• 34 Greenwood B N, Foley T E, Burhans D J. et al . The consequences of uncontrollable stress are sensitive to the duration of prior wheel running.  Brain Res. 2005;  1033 164-178
• 35 Berchtold N C, Kesslak J P, Pike C J. et al . Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus.  Eur J Neurosci. 2001;  14 1992-2002
• 36 Carro E, Nunez A, Busiguina S. et al . Circulating insulin-like growth factor I mediates effects of exercise on the brain.  J Neurosci. 2000;  20 2926-2933
• 37 Gomez-Pinilla F, Dao L, So V. Physical exercise induces FGF-2 and its mRNA in the hippocampus.  Brain Res. 1997;  764 1-8
• 38 Russo-Neustadt A A, Beard R C, Huang Y M. et al . Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus.  Neuroscience. 2000;  101 305-312
• 39 Van Praag H, Christie B R, Sejnowski T J. et al . Running enhances neurogenesis, learning and long-term potentiation in mice.  Proc Natl Acad Sci USA. 1995;  96 13 427-13 431
• 40 Schinder A F, Gage F H. A hypothesis about the role of adult neurogenesis in hippocampal function.  Physiology. 2004;  9 253-261
• 41 Elder G A, De Gasperi R, Gama Sosa M A. Research update: neurogenesis in adult brain and neuropsychiatric disorders.  Mt Sinai J Med. 2006;  73 31-40
• 42 Ernst C, Olson A K, Pinel J P. et al . Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis?.  J Psychiatry Neurosci. 2006;  31 84-92
• 43 Blumenthal J A, Fredrikson M, Matthews K A. et al . Stress activity and exercise training in premenopausal and postmenopausal women.  Health Psychol. 1991;  10 384-391
• 44 Wittert G A, Livesey J H, Espiner E A. et al . Adaption of the hypothalamopituitary adrenal axis to chronic exercise stress in humans.  Med Sci Sports Exerc. 1996;  28 1015-1019
• 45 Dishman R K. Brain monoamines, exercise and behavioural stress: animal models.  Med Sci Sports Exerc. 1997;  29 63-74
• 46 Bjornebekk A, Mathe A A, Brene S. The antidepressant effect of running is associated with increased hippocampal cell proliferation.  Int J Neuropsychopharmacol. 2005;  8 357-368
• 47 Gronli J, Bramham C, Murison R. et al . Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper.  Pharmcol Biochem Behav. 2006;  85 842-849
• 48 Lawlor D A, Hopker S W. The effectiveness of exercise as an intervention in the management of depression: Systematic review and meta-regression analysis of randomised trials.  BMJ. 2001;  322 1-8
• 49 Blumenthal J A, Babyak M A, Moore K A. et al . Comparison of aerobic exercise in older patients with major depression.  Arch Intern Med. 1999;  159 (19) 2349-2356
• 50 Martinsen E W, Hoffart A, Solberg O. Comparing aerobic with nonaerobic forms of exercise in the treatment of clinical depression: A randomized trial.  Compr Psychiatry. 1989 a;  30 324-331
• 51 Veale D, Le Fevre K, Pantelis C. et al . Aerobic exercise in the adjunctive treatment of depression a randomised controlled trial.  J R Soc Med. 1992;  85 541-544
• 52 Broocks A. Psychiatrische Funktionsstörungen. In: Reimers CD, Broocks A, Hrsg Neurologie, Psychiatrie und Sport. Stuttgart, New York; Thieme 2003: 180-217
• 53 Broocks A, Bandelow B, Pekrun G. et al . Comparison of aerobic exercise, clomipramine and placebo in the treatment of panic disorder.  Am J Psychiat. 1998;  155 603-609
• 54 Oja P. Dose response between total volume of physical activity and health and fitness.  Med Sci Sports Exerc. 2001;  3, Suppl 428-437
• 55 Reimers C D. Gesundheitliche Auswirkungen körperlicher Aktivität. In: Reimers CD, Broocks A, Hrsg Neurologie, Psychiatrie und Sport. Stuttgart, New York; Thieme 2003: 46-55
• 56 Broocks A, Ahrendt U, Sommer M. Körperliches Training in der Behandlung depressiver Erkrankungen.  Psychiat Prax. 2007;  34 S300-S304